Paige AI

Paige AI is a heavyweight in computational pathology, offering diagnostic suites for prostate, breast, GI, and pan-cancer applications. Its foundation models (Virchow2G) are among the largest, trained on 1.5M+ slides, enabling high accuracy and generalizability. Choose Paige if you need regulatory-compliant AI for clinical workflow integration, especially for prostate or breast cancer detection. Pass if you are a small lab with limited budget or need lightweight analytics without enterprise deployment. Compared to PathAI, Paige emphasizes foundation models and multi-modal co-pilot Alba, which offers voice/text commands—a unique feature. Real-world caveats: Implementation requires IT support and integration with existing digital pathology systems. The AI is assistive, not autonomous, so pathologists must validate results. Pricing is not public, likely requiring a sales quote.

Paige AI is a leader in applying artificial intelligence to pathology, offering AI-assisted diagnostic and biomarker applications to support cancer detection, subtyping, and molecular biomarker discovery from tissue samples. Designed for pathologists, oncologists, and life sciences researchers, Paige's tools alleviate time and resource pressures, enabling informed, quality diagnoses. Key features include the Paige Prostate Suite for prostate cancer detection, Paige Breast Suite for breast cancer classification, Paige GI Suite for gastrointestinal tract conditions, and PanCancer Suite for multiple tissue types including rare cancers. Paige also provides AI technology and services through foundation models (Virchow, Virchow2, Virchow2G, Virchow2G-Mini, PRISM) and offers PaGen AI modules for therapeutic targeting and biomarker identification. Their new co-pilot, Paige Alba, integrates voice and text commands for real-time insights. Paige stands out for its foundation model approach, trained on over 1.5 million slides, and its focus on clinical-grade AI for cancer care.